Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.059x

Based on the latest financial reports, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a cash flow conversion efficiency ratio of 0.059x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.10 Billion ≈ $2.45 Billion USD) by net assets (€35.38 Billion ≈ $41.36 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see GU5 market cap overview for the company's overall valuation and market capitalisation.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited ranked by their cash flow conversion efficiency. Explore Guangzhou Baiyunshan Pharmaceutical Hold earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Checkpoint Therapeutics Inc NASDAQ:CKPT	-0.717x
Waterstone Financial Inc NASDAQ:WSBF	0.027x
Chengdu Huasun Group Inc Ltd SHE:000790	-0.142x
Guangdong Jingyi Metal Co Ltd SHE:002295	0.064x
Alantra Partners S.A. MC:ALNT	0.020x
Brunel International NV AS:BRNL	-0.021x
Meteoric Resources NL F:RNF	-0.820x
CMC Magnetics Corp TW:2323	0.000x

Annual Cash Flow Conversion Efficiency for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)

The table below shows the annual cash flow conversion efficiency of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025. View Guangzhou Baiyunshan Pharmaceutical Hold share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€40.08 Billion ≈ $46.86 Billion	€-232.46 Million ≈ $-271.77 Million	-0.006x	-106.36%
2024-12-31	€37.77 Billion ≈ $44.16 Billion	€3.44 Billion ≈ $4.02 Billion	0.091x	-18.54%
2023-12-31	€36.68 Billion ≈ $42.88 Billion	€4.10 Billion ≈ $4.80 Billion	0.112x	-46.23%
2022-12-31	€33.64 Billion ≈ $39.33 Billion	€7.00 Billion ≈ $8.18 Billion	0.208x	+14.89%
2021-12-31	€31.33 Billion ≈ $36.62 Billion	€5.67 Billion ≈ $6.63 Billion	0.181x	+772.92%
2020-12-31	€28.21 Billion ≈ $32.97 Billion	€585.19 Million ≈ $684.14 Million	0.021x	-89.26%
2019-12-31	€25.99 Billion ≈ $30.38 Billion	€5.02 Billion ≈ $5.87 Billion	0.193x	-14.27%
2018-12-31	€23.14 Billion ≈ $27.06 Billion	€5.22 Billion ≈ $6.10 Billion	0.225x	+136.80%
2017-12-31	€19.26 Billion ≈ $22.52 Billion	€1.83 Billion ≈ $2.14 Billion	0.095x	-33.96%
2016-12-31	€17.65 Billion ≈ $20.64 Billion	€2.54 Billion ≈ $2.97 Billion	0.144x	-35.54%
2015-12-31	€8.68 Billion ≈ $10.15 Billion	€1.94 Billion ≈ $2.27 Billion	0.224x	+1.31%
2014-12-31	€7.92 Billion ≈ $9.26 Billion	€1.75 Billion ≈ $2.04 Billion	0.221x	+15.99%
2013-12-31	€7.02 Billion ≈ $8.21 Billion	€1.34 Billion ≈ $1.56 Billion	0.190x	--

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

F:GU5 Germany Medical Distribution

Market Cap

$367.63 Million

€314.46 Million EUR

Market Cap Rank

#13963 Global

#1417 in Germany

Share Price

€1.43

Change (1 day)

+0.70%

52-Week Range

€1.42 - €2.30

All Time High

€2.30